不同方式诱导人卵巢癌顺铂耐药细胞株的比较  被引量:29

Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines

在线阅读下载全文

作  者:程国钧[1] 李亚里[1] 田方[2] 祝华 孙丽亚[2] 李春海[2] 杨秀玉[3] 

机构地区:[1]解放军总医院妇产科,北京100853 [2]军事医学科学院 [3]北京协和医院妇产科

出  处:《中华肿瘤杂志》2001年第4期305-308,共4页Chinese Journal of Oncology

基  金:全军“九五”医学科研规划重点课题资助项目(96Z055)

摘  要:目的 研究不同诱导方式建立的卵巢癌顺铂耐药细胞株的耐药机理。方法 采用大剂量冲击法和浓度梯度递增法建立卵巢癌顺铂耐药细胞株Skov3/CDDP P和Skov3/CDDP 5 0。结果Skov3/CDDP P和Skov3/CDDP 5 0的耐药指数分别为 3.7和 48.6 ,伴有形态改变、生长减慢、细胞周期改变等。耐药细胞株的细胞内药物浓度降低 ,与多药耐药相关基因 (MDR1)、多药耐药相关蛋白(MRP)和肺耐药蛋白 (LRP)的表达增强有关。谷胱甘肽S转移酶 (GST π)的表达无明显变化 ,拓朴异构酶Ⅱ (TOPOⅡ )活性轻度下降。不同诱导方式存在差异。结论 顺铂耐药涉及多个相关基因的表达 ,持续诱导方式容易产生耐药。Objective To investigate the mechanism responsible for acquired cisplatin resistance induced in human ovarian cancer cell lines by different methods. Methods Two resistant cell lines, Skov3/CDDP P and Skov3/CDDP 50, were established by pulse or stepwise exposures of ovarian cancer cell line Skov3 to cisplatin (CDDP) for 10 12 months with the drug sensitivity monitored by MTT test. The growth rate and cell cycle were compared. The intracellular drug concentration was measured by FACS after 1 hour incubation in 20 μmol/L ADM. The drug resistance associated genes: MDR1, MRP, LRP and GST π were monitored by RT PCR and western blotting. Results The resistance indexes (RI) of Skov3/CDDP P and Skov3/CDDP 50 were 3.7 and 48.6 to cisplatin, 4.0 and 33.0 to Taxol, 2.2 and 7.3 to adriamycin, 1.5 and 3.4 to VP16, and the intracellular ADM concentration was lowered by 34.6% and 47.2% respectively. Both resistant cell lines grew slowly and exhibited changes in morphology and cell cycle. The expression of the resistance associated genes MDR1, MRP and LRP was enhanced in both resistant cell lines. However, Skov3/CDDP 50 showed greater increase in MDR1 but Skov3/CDDP P showed more in MRP. There were no significant changes in GST π expression either at mRNA or protein level. The TOPO Ⅱ activity decreased slightly in both resistant cell lines. Conclusion Stepwise induction of cisplatin resistance in ovarian cancer is more readily acquired in which multiple drug resistance associated genes are involved.

关 键 词:卵巢肿瘤 顺铂 多药耐药 基因表达 

分 类 号:R737.31[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象